Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study

被引:8
|
作者
Dhungana, Govinda Prasad [1 ]
Thekkur, Pruthu [2 ,3 ]
Chinnakali, Palanivel [4 ]
Bhatta, Usha [5 ]
Pandey, Basudev [6 ]
Zhang, Wei-Hong [7 ,8 ]
机构
[1] Far Western Univ, Fac Sci & Technol, Mahendranagar, Nepal
[2] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France
[3] Union South East Asia Off, Ctr Operat Res, New Delhi, India
[4] JIPMER, Dept Prevent & Social Med, Pondicherry, India
[5] Natl Ctr AIDS & STD Control, Kathmandu, Nepal
[6] Sukraraj Trop & Infect Dis Hosp, Kathmandu, Nepal
[7] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, ICRH, Ghent, Belgium
[8] ULB, Sch Publ Hlth, Fac Med, Res Lab Human Reprod, Brussels, Belgium
来源
BMJ OPEN | 2019年 / 9卷 / 05期
关键词
CASE NOTIFICATION RATES; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; TUBERCULOSIS INCIDENCE; PILOT PROGRAM; SCALE-UP; ADULTS; IMPLEMENTATION; PREDICTORS; ADHERENCE;
D O I
10.1136/bmjopen-2019-029058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6 months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of Nepal. Design We conducted a retrospective cohort study using secondary data extracted from registers maintained at ART centres. Setting All 11 ART centres in the FWR of Nepal. Participants All PLHIV registered for care between January 2016 and December 2017 in 11 ART centres. Primary outcome measures IPT initiation and completion rates were summarised as percentages with 95% CI. Independent association between patient characteristics and non-initiation of IPT was assessed using cluster-adjusted generalised linear model (log binomial regression) and adjusted relative risk (RR) with 95% CI was calculated. Result Of the 492 PLHIV included, 477 (97.0%) did not have active TB at registration. Among 477 without active TB, 141 (29.8%, 95% CI 25.7% to 34.1%) had been initiated on IPT and 85 (17.8%) were initiated within 3 months of registration. Of 141 initiated on IPT, 133 (94.3%, 95% CI 89.1% to 97.5%) had completed 6 months of IPT. Being more than 60 years of age (RR-1.3, 95% CI 1.1 to 1.7), migrant worker (RR-1.3, 95% CI 1.1 to 1.4) and not being initiated on ART (RR-1.4, 95% CI 1.1 to 1.8) were significantly associated with IPT initiation. Conclusions In FWR of Nepal, three out of 10 eligible PLHIV had received IPT. Among those who have received IPT, the completion rate was good. The HIV care programme needs to explore the potential reasons for this low coverage and take context specific corrective action to fix this gap.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland
    Adams, L. V.
    Mahlalela, N.
    Talbot, E. A.
    Pasipamire, M.
    Ginindza, S.
    Calnan, M.
    Haumba, S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (10) : 1127 - 1132
  • [2] Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016)
    Maokola, Werner
    Ngowi, Bernard
    Lawson, Lovetti
    Robert, Masanja
    Mahande, Michael
    Todd, Jim
    Msuya, Sia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 562 - 567
  • [3] Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006–2011
    Laxmi Bhatta
    Elise Klouman
    Keshab Deuba
    Rachana Shrestha
    Deepak Kumar Karki
    Anna Mia Ekstrom
    Luai Awad Ahmed
    BMC Infectious Diseases, 13
  • [4] Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006-2011
    Bhatta, Laxmi
    Klouman, Elise
    Deuba, Keshab
    Shrestha, Rachana
    Karki, Deepak Kumar
    Ekstrom, Anna Mia
    Ahmed, Luai Awad
    BMC INFECTIOUS DISEASES, 2013, 13
  • [5] EFFECT OF COMMUNITY BASED INTERVENTION ON ISONIAZID PREVENTIVE THERAPY UPTAKE AMONG PEOPLE LIVING WITH HIV IN FAR WESTERN PROVINCE OF NEPAL: A CLUSTER RANDOMIZED CONTROLLED TRIAL
    Dhungana, G.
    Bhatta, D. R.
    Zhang, W. H.
    VALUE IN HEALTH, 2021, 24 : S116 - S117
  • [6] Effectiveness of a six-month Isoniazid as tuberculosis preventive therapy in people living with HIV in eritrea: A retrospective cohort study
    Russom, Mulugeta
    Stricker, Bruno
    Woldu, Henok G.
    Berhane, Araia
    Jeannetot, Daniel
    Verhamme, Katia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 209 - 210
  • [7] Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors
    Adepoju, Abiola Victor
    Ogbudebe, Chidubem L.
    Adejumo, Olusola Adedeji
    Okolie, Johnson
    Inegbeboh, Jude O.
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (02) : 105 - 111
  • [8] Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data
    Karanja, Muthoni
    Kingwara, Leonard
    Owiti, Philip
    Kirui, Elvis
    Ngari, Faith
    Kiplimo, Richard
    Maina, Maurice
    Masini, Enos
    Onyango, Elizabeth
    Ngugi, Catherine
    PLOS ONE, 2020, 15 (12):
  • [9] Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe
    Takamiya, Mayuko
    Takarinda, Kudawashe
    Balachandra, Shrish
    Godfrey, Musuka
    Radin, Elizabeth
    Hakim, Avi
    Pearson, Michelle L.
    Choto, Regis
    Sandy, Charles
    Maphosa, Talent
    Rogers, John H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (11) : 1020 - 1027
  • [10] Completion Rates and Hepatotoxicity of Isoniazid Preventive Therapy Among Children Living with HIV/AIDS: Findings and Implications in Northwestern Nigeria
    Ogunyinka, Ibrahim Abayomi
    Wada, Yusuf Hassan
    Bolajoko, Tajudeen
    Tahir, Yusuf
    Oshikoya, Kazeem Adeola
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (10) : 455 - 466